These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 87021)

  • 21. False HLA--D assignments may be caused by cytotoxic responder lymphocytes.
    Kristensen T; Jørgensen F
    Tissue Antigens; 1978 May; 11(5):443-8. PubMed ID: 80833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An estimation of the recombination fraction between the MLC locus and the FOUR locus.
    Keuning JJ; van den Tweel JG; Gabb BW; Termijtelen A; Goulmy E; Blokland E; Elferink BG; van Rood JJ
    Tissue Antigens; 1975 Sep; 6(3):107-15. PubMed ID: 52907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-D compatibility between parent and child: increased occurrence in severe combined immunodeficiency and other hematopoietic diseases.
    Hansen JA; Good RA; Dupont B
    Transplantation; 1977 Apr; 23(4):366-74. PubMed ID: 17183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigenic complexity of the HLA-D region as defined by homozygous typing cells and primed lymphocyte tests.
    Reinsmoen N; Hansen J; Dupont B; Gatti R; Yunis E
    Transplant Proc; 1977 Dec; 9(4):1767-9. PubMed ID: 74881
    [No Abstract]   [Full Text] [Related]  

  • 25. Statistical methods for studying homozygous typing cells of unknown specificity.
    Mendell NR; Johnson AH; Ward FE; Hartzman RJ; Phillips EA; Ayres J; Amos DB; Ciftan EA
    Hum Immunol; 1981 Mar; 2(2):125-38. PubMed ID: 6167555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitation of HLA-D differences.
    Suciu-Foca N; Rubinstein P; Susinno E; Broell J; Weiner J; Reemtsma K
    Tissue Antigens; 1978 Aug; 12(2):94-105. PubMed ID: 81541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of HLA-DR matching for nonreactivity in mixed lymphocyte culture (MLC) depends on matching for HLA-D.
    Vaidya S; Colbaugh P; Stastny P
    Transplant Proc; 1979 Dec; 11(4):1779-80. PubMed ID: 93804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigens associated with acute leukemia detected in the primed lymphocyte test.
    Reinsmoen NL; Kersey JH; Yunis EJ
    J Natl Cancer Inst; 1978 Mar; 60(3):537-43. PubMed ID: 146747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotyping for MLC gene products. II. ABCIL detection of HLA-D specificities by the "tandem" technique, using multiparous sera before and after absorption with HLA-D homozygous lymphocytes.
    Kovithavongs T; Marchuk L; Schlaut J; Dossetor JB
    Transplant Proc; 1977 Mar; 9(1):445-9. PubMed ID: 141131
    [No Abstract]   [Full Text] [Related]  

  • 30. Linkage relationship of C2 deficiency, HLA and glyoxalase I loci.
    Mahowald ML; Dalmasso AP; Petzel RA; Yunis EJ
    Vox Sang; 1979; 37(6):321-8. PubMed ID: 161677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MHC specified lymphocyte activating and suppressor activating determinants in human mixed lymphocyte reactions.
    Fainboim L; Jaraquemada D; Festenstein H; Sachs JA
    Scand J Immunol; 1981 Dec; 14(6):655-67. PubMed ID: 6177031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mixed lymphocyte culture (MLC) as a histocompatibilty test for allogen grafts. Part I: HLA-D locus: genetics and typing (author's transl)].
    Moser C; Vogel I
    Wien Klin Wochenschr; 1977 Oct; 89(19):637-40. PubMed ID: 143798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The HLA complex. II. Immunogenetics of the HLA system. The allelic HLA-D series and the specificities of lymphocyte subpopulations].
    Dausset J
    Nouv Presse Med; 1976 May; 5(21):1353-7. PubMed ID: 59343
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of unrelated HLA-identical bone marrow donors: RFLP, oligotyping and PCR fingerprinting for HLA class II compared to MLC responses.
    Mazzola G; el-Borai MH; Berrino M; Cornaglia M; Amoroso A
    Bone Marrow Transplant; 1993; 11 Suppl 1():24-7. PubMed ID: 8095414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The specificity of secondary MLC assayed by titration of primed lymphocyte populations.
    Singal DP
    Tissue Antigens; 1979 Jul; 14(1):22-31. PubMed ID: 91217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Possibilities of finding identical HLA donor-recipient pairs for bone marrow transplantation].
    Buc M; Niks M; Bláha M; Steruská M; Mistrík M
    Bratisl Lek Listy; 1990 Jul; 91(7):516-20. PubMed ID: 2145057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MLC (HLA-D) typing: a family study.
    Jørgensen F; Kristensen T; Lamm LU; Kissmeyer-Nielsen F
    Tissue Antigens; 1977 Nov; 10(5):379-93. PubMed ID: 75583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Reactions of primed lymphocytes (PLT) and their genetic determination (author's transl)].
    Hajek-Rosenmayr A
    Wien Klin Wochenschr; 1982 Jan; 94(1):13-9. PubMed ID: 6177103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of HLA-A, B or HLA-D identity on the MIF production in MLC.
    Stenbjerg S; Mygind K; Jorgensen F
    Acta Pathol Microbiol Scand C; 1976 Jun; 84(3):210-4. PubMed ID: 63222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discrimination value of class III and glyoxalase alleles for selection of histocompatible bone marrow donors.
    Wölpl A; Goldmann SF; Eiermann T; Arnold R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2632-5. PubMed ID: 2950638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.